Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Smoking Cessation
100%
Bupropion
100%
Abstinence Rate
100%
CYP2B6 Genotype
100%
Cytochrome P450 2D6 (CYP2D6)
100%
Placebo
40%
End of Treatment
40%
6-month Follow-up
40%
Genotype
30%
Smokers
30%
Metabolism
20%
Confidence Interval
20%
Odds Ratio
20%
Clinical Trials
10%
GlaxoSmithKline
10%
Treatment Outcome
10%
Adverse Effects
10%
Genetic Polymorphism
10%
North Carolina
10%
Treatment Interaction
10%
Point-prevalence Abstinence
10%
Urge to Smoke
10%
Zyban
10%
Treatment Start
10%
Medicine and Dentistry
Nicotine Withdrawal
100%
Bupropion
100%
Abstinence
100%
CYP2B6
100%
Placebo
36%
Odds Ratio
18%
Clinical Trial
9%
Prevalence
9%
Enzymes
9%
Genetic Polymorphism
9%
Treatment Outcome
9%
Adverse Effect
9%
Nursing and Health Professions
Nicotine Withdrawal
100%
Bupropion
100%
CYP2B6
100%
Placebo
36%
Odds Ratio
18%
Confidence Interval
18%
Treatment Outcome
9%
Prevalence
9%
Enzymes
9%
Clinical Trial
9%
Adverse Effect
9%
Neuroscience
Bupropion
100%
CYP2B6
100%
Placebo
36%
Metabolic Pathway
18%
Enzymes
9%
Genetic Polymorphism
9%
Adverse Effect
9%
Pharmacology, Toxicology and Pharmaceutical Science
Bupropion
100%
CYP2B6
100%
Placebo
36%
Clinical Trial
9%
Prevalence
9%
Enzymes
9%
Adverse Effect
9%
Psychology
Clinical Trial
100%
Adverse Effect
100%